NEW YORK (GenomeWeb News) – Stan Lapidus is the founder, president, and CEO of SynapDx, a new company developing diagnostic tests for the early detection of autism. He is a co-founder of Helicos BioSciences, Cytyc, and Exact Sciences.
The EPEMED European personalized medicine association has appointed Anne Bruinvels to be executive director and a board member. Bruinvels will work to expand the new organization and build its strategic framework.
Bruinvels has previously worked at Elixior and was CEO at Curidium, both of which are personalized healthcare companies. She also has worked in research at SmithKline Beecham, Wyeth, and Sandoz Pharma. She earned her PhD in neuroscience at Utrecht University and her MSc in pharmacy from Groningen University.
Jack Goldstein has been named a member of Accuray's board of directors, the radiosurgery firm said recently. Goldstein, an independent consultant, was most recently president and chief operating officer of Chiron. He was also general partner at Windamere Venture Partners, and before that president and CEO at Applied Imaging.
Goldstein serves on the board of directors of OncoGenex Pharmaceuticals and Orasure Technologies. He previously served on the boards of Applied Imaging, Immucor, and Illumina.